00:00:00
Lihteh Wu (Costa Rica) - Welcome & Introduction of Keynote Speaker
00:02:12
R.V. Paul Chan (USA) - Keynote lecture: Innovations in ROP Management: The PAAO and Global Collaborations
00:30:50
Cody Lo (Canada) - Risk of Requiring Glaucoma Surgery following Intravitreal anti-VEGF Injections: A Case-Control Study
00:36:15
David Sousa (Portugal) - Retinal vascular reactivity in type 1 diabetes patients without retinopathy using optical coherence tomography angiography
00:42:55
Anastasiya Vinokurtseva (Canada) - Treatment of ocular inflammation: effects of COX-2 acetylating immuno-resolvents (CAIRs) in THP-1-derived macrophages and a rat model of endotoxin-induced uveitis
00:50:15
Bruno Ferreira (Brazil) - Assessment of Parafoveal Retinal Vasculature in Behçet’s Syndrome using Optical Coherence Tomography Angiography
00:57:30
Joana Mesquita (Portugal) - Comparison of Vascular Endothelial Growth Factors (VEGFs) A and B with diabetic retinopathy severity and diabetic macular edema. Correlation between growth factors and anatomical parameters
01:02:41
Christos Boutopoulos (Canada) - A smart vitrector equipped by a fiber-based OCT sensor mitigates simulated iatrogenic retinal injuries during vitrectomy in pigs
01:10:00
María Madeira (Portugal) - Retinal neurodegeneration in type 2 diabetic individuals with mild retinopathy is independent of retinopathy severity progression: a 5-year longitudinal study
01:17:17
María Esther Santos Blanco (Spain) - Retiprogram: A Clinical Decision Support System for Diabetic Retinopathy with Predictive Value
01:22:30
Anne Xuan-Lan Nguyen (Canada) - Correlating retinal blood vessel movements with other clinical signs in progressing retinal degenerations
01:30:10
Manlong Xu (Canada) - How do RA and SLE patients differ while on long-term hydroxychloroquine therapy?
01:35:10
Armin Farahvash (Canada) - Understanding the Mechanism of Retinal Displacement Following Surgical Management of Rhegmatogenous Retinal Detachment: A Computer Simulation Model
01:42:50
Ojas Srivastava (Canada) - Anti-VEGF switch therapy from bevacizumab to aflibercept in radiation retinopathy secondary to uveal melanoma
01:47:50
Ivan Fernandez-Bueno (Spain) - Retinal cells death rates in in vitro neuroretinal degeneration model: preliminary data
01:52:56
Supriya Arora (Bahamas) - One year outcome and predictors of treatment outcome in central serous chorioretinopathy (CSCR): multimodal imaging based analysis
01:58:25
Simrat Sodhi (United Kingdom) - Utilisation of Machine Learning to quantify fluid volume of wet age-related macular degeneration (wARMD) patients based on swept-source optical coherence tomography (SS-OCT) imaging: The ONTARIO Study
02:01:42
Tomás Loureiro (Portugal) - Quantitative Optical Coherence Tomography Angiography Biomarkers in a Treat-and-Extend Dosing Regimen in Neovascular Age-Related Macular Degeneration: A 24-Months Follow-up Study
02:06:58
Timothy Yu (Canada) - Collaborative Diabetic Retinopathy Severity Classification of Optical Coherence Tomography Data through Federated Learning
02:11:23
Paula Subirada Caldarone (Argentina) - The neurotrophin receptor p75NTR as a new player in the development of choroidal neovascularization
02:17:23
Kenzo Tomishige (Brazil) - Comparison of depressive symptoms between age-related macular degeneration and glaucoma patients who live in a developing country
02:23:00
Natalia Binczyk (Canada) - Frequency of anti-VEGF intravitreal injections (IVI) after post-injection endophthalmitis in patients with neovascular age related macular degeneration (nvD)
02:26:19
Deborah Villafranca-Baughman (Canada) - Glia-derived S100ß promotes pericyte-mediated capillary constriction and reduced blood flow in glaucomatous and ischemic retinas
02:30:39
Inés López Cuenca (Spain) - Assessment of macular thickness changes by OCT in asymptomatic relatives of Alzheimer’s disease patients
02:34:44
Sabiha Hacibekiroglu (Canada) - Safe and immune-tolerant ‘designer’ RPE cells towards the treatment of age-related macular degeneration
02:40:32
Mariana da Palma (Brazil) - Phenotypic and genotypic spectrum of HGSNAT-related retinopathy
02:45:20
Elena Salobrar-García (Spain) - Choroidal changes as a biomarker of cerebral amyloid angiopathy in mild Alzheimer’s disease patients
02:49:50
Inés Marques (Portugal) - Microaneurysm Turnover in eyes with mild nonproliferative diabetic retinopathy is associated with progression and development of sight-threatening complications: a 5-year longitudinal study
02:54:35
Bonnie He (Canada) - Outcomes of scleral buckle after failed pneumatic retinopexy
03:00:40
Daniela Santos (Portugal) - ACE2-overexpression protects RPE cells from inflammation and oxidative stress
03:03:46
Diogo Bitoque (Portugal) - PAEMA nonviral vectors display enhanced gene transfer ability in retinal cells
03:07:02
Mohamed Abdouh (Canada) - Effects of Spectrum of Wavelengths of Blue-Light on Retinal Pigment Epithelial Cells
03:13:30
Christina Mastromonaco (Canada) - Drusen Quantification of Eye Bank Eyes Implanted with or without Blue-Light Filtering IOLs: a Histopathological Study
03:17:56
Arthur Nassaralla (Brazil) - Predominantely hemorragic lesion in nD and response to Anti-VEGF treatment
03:21:00
Prisca Bustamante (Canada) - Potential mechanism of action of Mifepristone as antitumor treatment in Uveal melanoma
03:24:15
Kelly Coutant (Canada) - Impact of melanomic extracellular vesicles in the metastatic process of uveal melanoma
03:27:40
Anna Camos-Carreras (Spain) - Functional tests and ganglion cell complex measured with optical coherence tomography in Autosomal Dominant Optic Atrophy
03:31:24
Sabrina Bergeron (Canada) - Optical biopsies of peri-ocular skin cancers: how OCT imaging can heighten accessibility to specialized healthcare by telemedicine
03:36:33
Gustavo Ortiz-Morales (Mexico) - CyberKnife Robot-Assisted Radiosurgery for Ciliochoroidal Melanoma: Early Results in Mexico
03:38:50
Final comments and announcement of Award recipients